Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › AK › Anchorage › NPI 1487102208
Physician

Neuroversion

Neuroversion was paid $4.52M by Medicaid between Jan 2018 and Dec 2024, across 40 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 39% of everything it billed.

33Billing provider infoNEUROVERSION
ANCHORAGE, AK 99508
33aNPI1487102208assigned 09/21/2016
28Total paid$4.52M
24GClaims74,490
24DCodes billed40
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service

Paid by month

$0$50K$100K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20188,343$460K
20199,187$497K
20208,537$463K
202111,426$644K
202214,153$790K
202312,903$818K
2024incomplete9,941$847K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 39% 18,768 16,419 $1.78M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 12% 7,992 7,180 $549K
64510 11% 3,138 1,611 $517K
76942 8.5% 6,697 4,327 $385K
64520 7.1% 1,414 846 $319K
99205 Prolong outpt/office vis 6.4% 1,415 1,377 $289K
99152 3.6% 3,708 2,691 $165K
77003 3.0% 1,425 863 $137K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.8% 1,409 854 $80K
64483 1.6% 310 288 $72K
99215 Doctor's office visit, returning patient (complex)Prolong outpt/office vis 1.1% 335 295 $48K
62370 <1% 661 618 $39K
28 more codes
62323 <1% 149 $30K
80305 <1% 3,015 $25K
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg <1% 2,251 $22K
20553 <1% 265 $15K
27096 <1% 40 $7K
64484 <1% 75 $7K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 152 $6K
J1030 Injection, methylprednisolone acetate, 40 mg <1% 1,161 $6K
20611 <1% 71 $6K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 1,731 $5K
62321 <1% 25 $4K
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 3,735 $4K
64530 <1% 12 $3K
64447 <1% 17 $2K
99153 Mod sedat endo service >5yrs <1% 195 $2K
64450 <1% 22 $1K
J3475 Injection, magnesium sulfate, per 500 mg <1% 4,933 $1K
62368 <1% 24 $501.04
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 642 $175.65
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 3,571 $150.20
J3010 Injection, fentanyl citrate, 0.1 mg <1% 3,103 $110.85
J7050 Infusion, normal saline solution, 250 cc <1% 24 $63.01
99406 <1% 15 $36.76
J3490 Unclassified drugs 0% 1,632 $0.00
J1010 Injection, methylprednisolone acetate, 1 mg 0% 120 $0.00
J7999 Compounded drug, not otherwise classified 0% 82 $0.00
J2795 Injection, ropivacaine hydrochloride, 1 mg 0% 15 $0.00
J0171 Injection, adrenalin, epinephrine, 0.1 mg 0% 141 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLIU, LUKE (OWNER)